Global Opioid-Induced Constipation Market Research Report 2019

Table of Contents

Executive Summary

1 Opioid-Induced Constipation Market Overview

• 1.1 Product Overview and Scope of Opioid-Induced Constipation
• 1.2 Opioid-Induced Constipation Segment by Type
  • 1.2.1 Global Opioid-Induced Constipation Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Methylnaltrexone Bromide
  • 1.2.3 Lubiprostone
  • 1.2.4 Naloxegol
  • 1.2.5 Other
• 1.3 Opioid-Induced Constipation Segment by Application
  • 1.3.1 Opioid-Induced Constipation Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Pharmacy
  • 1.3.4 Other
• 1.4 Global Opioid-Induced Constipation Market by Region
  • 1.4.1 Global Opioid-Induced Constipation Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Opioid-Induced Constipation Market Size
  • 1.5.1 Global Opioid-Induced Constipation Revenue (2014-2025)
  • 1.5.2 Global Opioid-Induced Constipation Production (2014-2025)

2 Global Opioid-Induced Constipation Market Competition by Manufacturers

• 2.1 Global Opioid-Induced Constipation Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Opioid-Induced Constipation Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Opioid-Induced Constipation Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Opioid-Induced Constipation Production Sites, Area Served, Product Types
• 2.5 Opioid-Induced Constipation Market Competitive Situation and Trends
  • 2.5.1 Opioid-Induced Constipation Market Concentration Rate
  • 2.5.2 Opioid-Induced Constipation Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Opioid-Induced Constipation Production Market Share by Regions

• 3.1 Global Opioid-Induced Constipation Production Market Share by Regions
• 3.2 Global Opioid-Induced Constipation Revenue Market Share by Regions (2014-2019)
• 3.3 Global Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Opioid-Induced Constipation Production
  • 3.4.1 North America Opioid-Induced Constipation Production Growth Rate (2014-2019)
  • 3.4.2 North America Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Opioid-Induced Constipation Production
  • 3.5.1 Europe Opioid-Induced Constipation Production Growth Rate (2014-2019)
  • 3.5.2 Europe Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Opioid-Induced Constipation Production (2014-2019)
  • 3.6.1 China Opioid-Induced Constipation Production Growth Rate (2014-2019)
  • 3.6.2 China Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Opioid-Induced Constipation Production (2014-2019)
  • 3.7.1 Japan Opioid-Induced Constipation Production Growth Rate (2014-2019)
  • 3.7.2 Japan Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Opioid-Induced Constipation Consumption by Regions

• 4.1 Global Opioid-Induced Constipation Consumption by Regions
• 4.2 North America Opioid-Induced Constipation Consumption (2014-2019)
• 4.3 Europe Opioid-Induced Constipation Consumption (2014-2019)
• 4.4 China Opioid-Induced Constipation Consumption (2014-2019)
• 4.5 Japan Opioid-Induced Constipation Consumption (2014-2019)

5 Global Opioid-Induced Constipation Production, Revenue, Price Trend by Type

• 5.1 Global Opioid-Induced Constipation Production Market Share by Type (2014-2019)
• 5.2 Global Opioid-Induced Constipation Revenue Market Share by Type (2014-2019)
• 5.3 Global Opioid-Induced Constipation Price by Type (2014-2019)
• 5.4 Global Opioid-Induced Constipation Production Growth by Type (2014-2019)

6 Global Opioid-Induced Constipation Market Analysis by Applications

• 6.1 Global Opioid-Induced Constipation Consumption Market Share by Application (2014-2019)
• 6.2 Global Opioid-Induced Constipation Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Opioid-Induced Constipation Business

• 7.1 Takeda Pharmaceuticals
  • 7.1.1 Takeda Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
  • 7.1.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bayer
  • 7.2.1 Bayer Opioid-Induced Constipation Production Sites and Area Served
  • 7.2.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.2.3 Bayer Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Sanofi
  • 7.3.1 Sanofi Opioid-Induced Constipation Production Sites and Area Served
  • 7.3.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.3.3 Sanofi Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Mallinckrodt
  • 7.4.1 Mallinckrodt Opioid-Induced Constipation Production Sites and Area Served
  • 7.4.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.4.3 Mallinckrodt Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Salix (Bausch Health)
  • 7.5.1 Salix (Bausch Health) Opioid-Induced Constipation Production Sites and Area Served
  • 7.5.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.5.3 Salix (Bausch Health) Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 AstraZeneca
  • 7.6.1 AstraZeneca Opioid-Induced Constipation Production Sites and Area Served
  • 7.6.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.6.3 AstraZeneca Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Progenics Pharmaceuticals
  • 7.7.1 Progenics Pharmaceuticals Opioid-Induced Constipation Production Sites and Area Served
  • 7.7.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Purdue Pharm
  • 7.8.1 Purdue Pharm Opioid-Induced Constipation Production Sites and Area Served
  • 7.8.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.8.3 Purdue Pharm Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Nektar Therapeutics
  • 7.9.1 Nektar Therapeutics Opioid-Induced Constipation Production Sites and Area Served
  • 7.9.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.9.3 Nektar Therapeutics Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Daiichi Sankyo
  • 7.10.1 Daiichi Sankyo Opioid-Induced Constipation Production Sites and Area Served
  • 7.10.2 Opioid-Induced Constipation Product Introduction, Application and Specification
  • 7.10.3 Daiichi Sankyo Opioid-Induced Constipation Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Prestige
• 7.12 GSK
• 7.13 Shionogi

8 Opioid-Induced Constipation Manufacturing Cost Analysis

• 8.1 Opioid-Induced Constipation Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Opioid-Induced Constipation
• 8.4 Opioid-Induced Constipation Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Opioid-Induced Constipation Distributors List
• 9.3 Opioid-Induced Constipation Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Opioid-Induced Constipation Market Forecast

• 11.1 Global Opioid-Induced Constipation Production, Revenue Forecast
  • 11.1.1 Global Opioid-Induced Constipation Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Opioid-Induced Constipation Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Opioid-Induced Constipation Price and Trend Forecast (2019-2025)
• 11.2 Global Opioid-Induced Constipation Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Opioid-Induced Constipation Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Opioid-Induced Constipation Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Opioid-Induced Constipation Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Opioid-Induced Constipation Production, Revenue Forecast (2019-2025)
• 11.3 Global Opioid-Induced Constipation Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Opioid-Induced Constipation Consumption Forecast (2019-2025)
  • 11.3.2 Europe Opioid-Induced Constipation Consumption Forecast (2019-2025)
  • 11.3.3 China Opioid-Induced Constipation Consumption Forecast (2019-2025)
  • 11.3.4 Japan Opioid-Induced Constipation Consumption Forecast (2019-2025)
• 11.4 Global Opioid-Induced Constipation Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Opioid-Induced Constipation Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List